Mittal et al. [39] have demonstrated that this receptor is expressed in mouse and human tumor-infiltrating CD8+ T cells and that blocking TACTILE/CD155 interaction alone or in combination with anti-PD-1 or anti-TIGIT enhances CD8+ T cell function. Here, CD96 is linked to neoplasm.